Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect.
about
Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly(butylcyanoacrylate) nanoparticles.Targeted delivery of paclitaxel and doxorubicin to cancer xenografts via the nanoparticle of nano-diamino-tetrac.l-Peptide functionalized dual-responsive nanoparticles for controlled paclitaxel release and enhanced apoptosis in breast cancer cells
P2860
Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Lung cancer combination therap ...... rriers for synergistic effect.
@en
type
label
Lung cancer combination therap ...... rriers for synergistic effect.
@en
prefLabel
Lung cancer combination therap ...... rriers for synergistic effect.
@en
P2093
P2860
P1433
P1476
Lung cancer combination therap ...... rriers for synergistic effect.
@en
P2093
P2860
P304
P356
10.3109/10717544.2015.1055619
P407
P577
2015-06-16T00:00:00Z